Description
A tyrphostin that targets transforming Bcr-Abl fusion proteins (p185Bcr-Abl, p210Bcr-Abl, as well as normal c-Abl (IC50s = 4.3, 1, and 7.1 µM, respectively, for human proteins); also inhibits EGFR (IC50 = 0.25 µM)
Formal name: 4-[[(2,5-dihydroxyphenyl)methyl]amino]-benzoic acid, methyl ester
Synonyms: NSC 654705|Tyrphostin AG957
Molecular weight: 273.3
CAS: 140674-76-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Abl Family & Bcr-Abl||Product Type|Biochemicals|Kinase Inhibitors|EGFR/ErbB/HER Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|Abl family & Bcr-Abl Signaling||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling